If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,068.00    14.50 (1.38%)
Bid:
1,066.00
Ask:
1,067.00
Spread: 1.00 (0.094%)
Market Cap: £3.43b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director Appointment

13 Dec 2013 14:23

RNS Number : 5294V
Persimmon PLC
13 December 2013
 

 

Persimmon Plc (the "Company")

 

Directorate Change and Director Shareholding

 

Persimmon Plc is pleased to announce the appointment of David Jenkinson (B.A. Hons), North Division Chief Executive as an Executive Director with effect from 13 December 2013.

 

David Jenkinson (46) has been the Divisional Chief Executive of Persimmon's North Division since January 2013 with responsibility for twelve regions from the East Midlands to Scotland. He has worked in the housebuilding industry since 1995 and has a degree in Town & Country Planning. Mr Jenkinson has been with Persimmon for over 16 years and previous roles include Managing Director of Persimmon Homes North East and Regional Managing Director.

 

Nicholas Wrigley, Chairman, commented "Dave will bring a wealth of operational experience to the Board. His appointment again demonstrates the strength of our divisional management teams and the Company's ability to promote internal candidates to the Board in accordance with our succession planning policy."

 

There are no further details required to be disclosed pursuant to Listing Rule 9.6.13 in connection with Mr Jenkinson's appointment.

 

Following Mr Jenkinson's appointment to the Board an option has been granted to him today under the Persimmon Plc 2012 Long Term Incentive Plan (the Plan) over 460,523 shares at an option price of £11.355. This award is subject to the performance condition set out in the rules of the Plan, in summary being the return of £6.20 per share to shareholders by the end of 2021. The awards may vest up to 40% in December 2017 and the remainder in 2021.

 

As a result Mr Jenkinson holds options/awards over 1,698,567 ordinary shares granted under the Company's various share schemes.

 

The issued share capital of the Company on 13 December 2013 is 304,627,407 shares.

 

 

G N Francis

Group Company Secretary

 

 

 

 

Notes to Editors:

 

About Persimmon

Persimmon plc was established in 1972 and has become one of Britain's leading housebuilders. The Group's Head Office is in York and Persimmon has 24 regional offices nationwide. The Group operates under three main brands; Persimmon Homes, Charles Church and Westbury Partnerships.

 

The Persimmon Homes business builds quality houses which provide the very best in design, construction and service. Charles Church provides a range of premium houses, in both modern and traditional styles. Westbury Partnerships focuses on social housing using modern methods of construction supplied by Space4, our timber frame manufacturing business.

 

For more information about Persimmon please go to www.corporate.persimmonhomes.com 

 

Further information, please contact:

 

Persimmon plc Citigate Dewe Rogerson

Jeff Fairburn, Group Chief Executive Simon Rigby

Mike Killoran, Group Finance Director Kevin Smith

 

Tel: +44 (0)1904 642199 Tel: +44 (0)20 7638 9571

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFFFLDFDSEEE
Date   Source Headline
1st May 20252:20 pmRNSResult of AGM
1st May 20252:02 pmRNSTotal Voting Rights
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.